Br J Pharmacol 179(4):557570 Tuttle KR, Lakshmanan MC, Rayner B, Busch RS, Zimmermann AG, Woodward DB et al (2018a) Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
The medication selection represents one of the most significant differences between these platforms
Body contouring treatments aim to refine these changes and support more balanced body proportions
Can be used on the face and body
Effect of a multidisciplinary team approach in patients with diabetic foot ulcers on major adverse limb events (MALEs): systematic review and meta-analysis for the development of the Italian guidelines for the treatment of diabetic foot syndrome
During the Setting phase (months 69), participants refine their habits and set personalized goals, maintaining regular coach check-ins and app-based learning